Skip to main content

Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2023

  • Conference paper
  • First Online:
Experimental IR Meets Multilinguality, Multimodality, and Interaction (CLEF 2023)

Abstract

Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS) are chronic diseases that cause progressive or alternating neurological impairments in motor, sensory, visual, and cognitive functions. Affected patients must manage hospital stays and home care while facing uncertainty and significant psychological and economic burdens that also affect their caregivers. To ease these challenges, clinicians need automatic tools to support them in all phases of patient treatment, suggest personalized therapeutic paths, and preemptively indicate urgent interventions.

iDPP@CLEF aims at developing an evaluation infrastructure for AI algorithms to describe ALS and MS mechanisms, stratify patients based on their phenotype, and predict disease progression in a probabilistic, time-dependent manner.

iDPP@CLEF 2022 ran as a pilot lab in CLEF 2022, with tasks related to predicting ALS progression and explainable AI algorithms for prediction. iDPP@CLEF 2023 will continue in CLEF 2023, with a focus on predicting MS progression and exploring whether pollution and environmental data can improve the prediction of ALS progression.

G. Faggioli, A. Guazzo, S. Marchesin, L. Menotti and I. Trescato—These authors contributed equally.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    https://brainteaser.health/open-evaluation-challenges/.

  2. 2.

    https://www.kaggle.com/alsgroup/end-als.

  3. 3.

    https://dreamchallenges.org/dream-7-phil-bowen-als-prediction-prize4life/.

  4. 4.

    https://dx.doi.org/10.7303/syn2873386.

  5. 5.

    https://brainteaser.health/open-evaluation-challenges/idpp-2022/.

  6. 6.

    A more complete and detailed comparison, including the information for the other sub-task, is shown in the extended overview [6].

  7. 7.

    Results for sub-task b are available on the extended overview [6].

  8. 8.

    Results for sub-tasks b and c are available on the extended overview [6].

References

  1. Asamov, T., Aksenova, A., Ivanov, P., Boytcheva, S., Taskov, D.: Maximum likelihood estimation with deep learning for multiple sclerosis progression prediction. In: Aliannejadi, M., Faggioli, G., Ferro, N., Vlachos, M. (eds.) CLEF 2023 Working Notes (2023)

    Google Scholar 

  2. Branco, R., et al.: Investigating the impact of environmental data on ALS prognosis with survival analysis. In: Aliannejadi, M., Faggioli, G., Ferro, N., Vlachos, M. (eds.) CLEF 2023 Working Notes (2023)

    Google Scholar 

  3. Branco, R., et al.: Survival analysis for multiple sclerosis: predicting risk of disease worsening. In: Aliannejadi, M., Faggioli, G., Ferro, N., Vlachos, M. (eds.) CLEF 2023 Working Notes (2023)

    Google Scholar 

  4. Buonocore, T., et al.: Predicting and explaining risk of disease worsening using temporal features in multiple sclerosis notebook for the iDPP lab on intelligent disease progression prediction at clef 2023. In: CLEF 2023 Working Notes (2023)

    Google Scholar 

  5. Cedarbaum, J.M., et al.: The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J. Neurol. Sci. 169(1–2), 13–21 (1999)

    Article  Google Scholar 

  6. Faggioli, G., et al.: Overview of iDPP@CLEF 2023: the intelligent disease progression prediction challenge. In: Aliannejadi, M., Faggioli, G., Ferro, N., Vlachos, M. (eds.) CLEF 2023 Working Notes, CEUR Workshop Proceedings (CEUR-WS.org) (2023). ISSN 1613–0073

    Google Scholar 

  7. Guazzo, A., et al.: Intelligent disease progression prediction: overview of iDPP@CLEF 2022. In: Barron-Cedeno, A., et al. (eds.) Experimental IR Meets Multilinguality, Multimodality, and Interaction. CLEF 2022. LNCS, vol. 13390, pp. 395–422. Springer, Cham (2022). https://doi.org/10.1007/978-3-031-13643-6_25

  8. Guazzo, A., et al.: Overview of iDPP@CLEF 2022: the intelligent disease progression prediction challenge. In: Faggioli, G., Ferro, N., Hanbury, A., Potthast, M. (eds.) CLEF 2022 Working Notes, pp. 1130–1210, CEUR Workshop Proceedings (CEUR-WS.org) (2022). ISSN 1613–0073. http://ceur-ws.org/Vol-3180/

  9. Guazzo, A., Trescato, I., Longato, E., Tavazzi, E., Vettoretti, M., Camillo, B.: Baseline machine learning approaches to predict multiple sclerosis disease progression. In: Aliannejadi, M., Faggioli, G., Ferro, N., Vlachos, M. (eds.) CLEF 2023 Working Notes (2023)

    Google Scholar 

  10. Hagan, D.H., et al.: Calibration and assessment of electrochemical air quality sensors by co-location with regulatory-grade instruments. Atmos. Meas. Tech. 11(1), 315–328 (2018). ISSN 1867–8548, https://doi.org/10.5194/amt-11-315-2018

  11. Hanley, J.A., McNeil, B.J.: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143(1), 29–36 (1982). pMID: 7063747

    Google Scholar 

  12. Hanzl, M., Picek, L.: Predicting risk of multiple sclerosis worsening. In: Aliannejadi, M., Faggioli, G., Ferro, N., Vlachos, M. (eds.) CLEF 2023 Working Notes (2023)

    Google Scholar 

  13. Harrell, F.E.J., Califf, R.M., Pryor, D.B., Lee, K.L., Rosati, R.A.: Evaluating the yield of medical tests. JAMA 247(18), 2543–2546 (1982). ISSN 0098–7484

    Google Scholar 

  14. Karray, M.: Air pollution profiling through patient stratification: study of ALS staging systems usefulness in facilitating data-driven disease subtyping and discovery of hazardous ambient air pollutants. In: Aliannejadi, M., Faggioli, G., Ferro, N., Vlachos, M. (eds.) CLEF 2023 Working Notes (2023)

    Google Scholar 

  15. Küffner, R., et al.: Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nat. Biotechnol. 33(1), 51–57 (2015)

    Article  Google Scholar 

  16. Kurtzke, J.F.: Rating neurologic impairment in multiple sclerosis. Neurology 33(11), 1444–1444 (1983). ISSN 0028–3878, https://doi.org/10.1212/WNL.33.11.1444, https://n.neurology.org/content/33/11/1444

  17. Lombardi, A., et al.: Time-to-event interpretable machine learning for multiple sclerosis worsening prediction: results from iDPP@CLEF 2023. In: Aliannejadi, M., Faggioli, G., Ferro, N., Vlachos, M. (eds.) CLEF 2023 Working Notes (2023)

    Google Scholar 

  18. McKight, P.E., Najab, J.: Kruskal-wallis test. The corsini encyclopedia of psychology, p. 1 (2010)

    Google Scholar 

  19. Ramos, A., Martínez, P., González-Carrasco, I.: Hulat@iddp clef 2023: intelligent prediction of disease progression in multiple sclerosis patients. In: Aliannejadi, M., Faggioli, G., Ferro, N., Vlachos, M. (eds.) CLEF 2023 Working Notes (2023)

    Google Scholar 

  20. Rich, J.T., Neely, J.G., Paniello, R.C., Voelker, C.C., Nussenbaum, B., Wang, E.W.: A practical guide to understanding Kaplan-Meier curves. Otolaryngol.-Head Neck Surg. 143(3), 331–336 (2010)

    Article  Google Scholar 

  21. Rossi, I., Birolo, G., Fariselli, P.: iDPP@CLEF 2023 results from dsm-compbio unito. In: Aliannejadi, M., Faggioli, G., Ferro, N., Vlachos, M. (eds.) CLEF 2023 Working Notes (2023)

    Google Scholar 

  22. Tallarida, R.J., Murray, R.B., Tallarida, R.J., Murray, R.B.: Chi-Square Test. In: Manual of Pharmacologic Calculations: With Computer Programs, pp. 140–142. Springer, New York, NY (1987). https://doi.org/10.1007/978-1-4612-4974-0_43

  23. Vogt, M., Schneider, P., Castell, N., Hamer, P.: Assessment of low-cost particulate matter sensor systems against optical and gravimetric methods in a field co-location in Norway. Atmosphere 12(8), 961 (2021). ISSN 2073–4433, https://doi.org/10.3390/atmos12080961

Download references

Acknowledgments

The work reported in this paper has been partially supported by the BRAINTEASER (https://brainteaser.health/) project (contract n. GA101017598), as a part of the European Union’s Horizon 2020 research and innovation programme.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guglielmo Faggioli .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Faggioli, G. et al. (2023). Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2023. In: Arampatzis, A., et al. Experimental IR Meets Multilinguality, Multimodality, and Interaction. CLEF 2023. Lecture Notes in Computer Science, vol 14163. Springer, Cham. https://doi.org/10.1007/978-3-031-42448-9_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-42448-9_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-42447-2

  • Online ISBN: 978-3-031-42448-9

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics